Back to top
more

Better trading starts here.

Brokerage Reports

Research for CRL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

4 items in cart

View Cart/Checkout

Charles River Laboratories International, Inc. [CRL]

Reports for Purchase

Showing records 101 - 120 ( 384 total )

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 101

06/21/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for CRL 62122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 102

06/20/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 103

06/11/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for CRL 61122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 104

06/09/2022

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 105

06/08/2022

Company Report

Pages: 7

Lowers 2Q22, No Concerning Reads on LONN, CTLT, TMO, CDMO

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 106

06/02/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 107

06/01/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for CRL 6122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 108

05/17/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 109

05/11/2022

Company Report

Pages: 17

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 110

05/09/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 111

05/05/2022

Daily Note

Pages: 22

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 112

05/04/2022

Company Report

Pages: 6

No Biopharma Weakness Here - 1Q22

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 113

04/25/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 114

04/21/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 115

04/11/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 116

04/11/2022

Daily Note

Pages: 7

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 117

04/10/2022

Daily Note

Pages: 17

Life Science, Bioproduction, CROs: Positive Data Points for 2023

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 118

04/08/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 119

04/07/2022

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 120

04/06/2022

Daily Note

Pages: 3

Expands CRADL Footprint; Adds 100bps of Revenue Tailwind

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party